CLOUDBREAK THERAPEUTICS LLC SBIR Phase II Award, September 2018
A SBIR Phase II contract was awarded to CLOUDBREAK THERAPEUTICS LLC in September, 2018 for $1,932,619.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.